What is compounding?
Drug compounding is often regarded as the process of combining or mixing drugs to create a medication tailored to the needs of an individual patient.
The generic form of Vetmedin is Pimobendan.
Vetmedin is in limited supply. Orders placed will be shipped as product continues to come off backorder.
NOTE: Additional shipping charges may apply. This item DOES NOT qualify for free shipping. If additional shipping is required you will be
Vetivex Veterinary Lactated Ringer's Injection is a prescription, injectable electrolyte solution. It is commonly used to replace body fluid and minerals that are lost through dehydration, gastrointestinal diseases (vomiting and diarrhea), shock, and certain metabolic conditions. Vetivex Veterinary Lactated Ringer's Injection contains sodium lactate, sodium chloride, potassium chloride, and calcium chloride in a sterile fluid without preservatives. If your pet has been diagnosed or is being treated for dehydration, a metabolic disorder, or other medical condition that requires fluid and electrolyte supplementation, your veterinarian may prescribe at-home fluid injection. Consult with your veterinarian about the proper administration and use for your pet.
Vetivex Veterinary Lactated Ringer's Injection, USP is indicated as a source of water and electrolytes or as an alkalinizing agent.
As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient, as well as laboratory determinations.Parenteral drug products should be inspected visually for particulate matter anddiscoloration prior to administration whenever solution and container permit.
All solutions for injection contained in plastic containers are intended for administration using sterile equipment and aseptic technique.
Additives may be incompatible. Complete information is not available. Those additives known to be incompatible should not be used. Consult with pharmacist, if available. If, in the informed judgment of the veterinarian, it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced. Do not store solutions containing additives. Discard unused portion.
In an event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures.
See Warnings, Adverse Reactions and Precautions.
Tear overwrap down side at slit and remove solution bag. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired.
If supplemental medication is desired, follow directions below.
WARNING: Additives may be incompatible.
Federal las (U.S.A.) restricts this drug to use by or on the order of a licensed veterinarian.
Do not administer to horses by intraperitoneal injection.
Veterinary Lactated Ringer's Injection, USP should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there exists edema with sodium retention.
Veterinary Lactated Ringer's Injection, USP should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present.
Veterinary Lactated Ringer's Injection, USP should be used with great care in patients with metabolic or respiratory alkalosis. The administration of lactate ions should be done with great care in those conditions in which there is an increased level or an impaired utilization of these ions, such as severe hepatic insufficiency.
Veterinary Lactated Ringer's Injection, USP should not be administered simultaneously with blood through the same administration set because of the likelihood of coagulation.
The parenteral administration of Veterinary Lactated Ringer's Injection, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections.
In patients with diminished renal function, administration of Veterinary Lactated Ringer's Injection, USP may result in sodium or potassium retention.
Veterinary Lactated Ringer's Injection, USP is not for use in the treatment of lacticacidosis.
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venousthrombosis or phlebitis extending from the site of injection, extravasation, andhypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
Veterinary Lactated Ringer's Injection, USP must be used with caution. Excessadministration may result in metabolic alkalosis.
Caution must be exercised in the administration of Veterinary Lactated Ringer ?s Injection, USP to patients receiving corticosteroids or corticotropin. Do not administer unlesssolution is clear and seal is intact.
Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat.
It is recommended the product be stored in the moisture barrier overwrap at room temperature (25°C/77°F); brief exposure up to (40°C/104°F) does not adversely affect the product.
Just like LRS, VETIVEX Hartmann's should not be run through the same infusion set as blood products. The calcium in both LRS and VETIVEX Hartmann's can cause clotting and the possible development of microthrombi.
Based on experience from human medicine, some drugs should not be mixed with Hartmann's Solution. These include drugs containing oxalate, phosphate or carbonate/bicarbonate. Veterinarians should only add drugs to VETIVEX Hartmann's if they are sure they are safe to mix. Incompatibility has been reported with novobiocin sodium, oxytetra-cycline hydrochloride, sodium bicarbonate, sodium calcium edetate, and sulphadiazine sodium when mixed with Hartmann's Solution.